Amarin Corporation Loss Submission Form

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Amarin Corporation (NASDAQGM: AMRN) securities between September 24, 2018 and November 9, 2018.

According to the Amarin lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the top-line results Amarin touted about its REDUCE-IT trial for Vascepa were not as positive as the company represented; (2) the placebo given to patients in the control arm of REDUCE-IT may have increased the incidence of cardiovascular events in those patients; (3) as a result, Amarin's public statements were materially false and misleading at all relevant times.

If you suffered a loss in Amarin you have until April 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

To receive more information, please fill out the form.

Submit Your Information

This submission does not create an attorney-client relationship. By submitting your information, you are giving us your express consent to contact you by email, text message, SMS, or call you by telephone.

Privacy Policy